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Abstract 42 
Glycans are major nutrients for the human gut microbiota (HGM). Arabinogalactan 43 
proteins (AGPs) comprise a heterogenous group of plant glycans in which a β1,3-44 
galactan backbone and β1,6-galactan side chains are conserved. Diversity is provided 45 
by the variable nature of the sugars that decorate the galactans. The mechanisms by 46 
which nutritionally relevant AGPs are degraded in the HGM are poorly understood. 47 
Here we explore how the HGM organism Bacteroides thetaiotaomicron metabolises 48 
AGPs. We propose a sequential degradative model in which exo-acting glycoside 49 
hydrolase (GH) family 43 β1,3-galactanases release the side chains. These 50 
oligosaccharide side chains are depolymerized by the synergistic action of exo-acting 51 
enzymes in which catalytic interactions are dependent on whether degradation is 52 
initiated by a lyase or GH. We identified two GHs that establish two previously 53 
undiscovered GH families. The crystal structures of the exo-β1,3-galactanases 54 
identified a key specificity determinant and departure from the canonical catalytic 55 
apparatus of GH43 enzymes. Growth studies of Bacteroidetes spp. on complex AGP 56 
revealed three keystone organisms that facilitated utilisation of the glycan by 17 57 
recipient bacteria, which included B. thetaiotaomicron. A surface endo-β1,3-58 
galactanase, when engineered into B. thetaiotaomicron, enabled the bacterium to 59 
utilise complex AGPs and act as a keystone organism.  60 
 61 
    62 
The human gut microbiota (HGM) contributes to the physiology and health of its host1. 63 
Glycans, the major nutrients for the HGM, are degraded primarily by Bacteroides species 64 
within this ecosystem2-4. Understanding glycan utilisation in the HGM underpins prebiotic 65 
and probiotic strategies that promote human health. Glycan degradation is mediated by 66 
carbohydrate active enzymes (CAZymes), primarily glycoside hydrolases (GHs) and 67 
polysaccharide lyases (PLs)5, which are grouped into sequence-based families on the CAZy 68 
database (http://www.cazy.org/)6. Although there is structural and catalytic conservation 69 
within families, substrate specificity may vary7. Genes encoding glycan degrading systems 70 
are up-regulated by the target carbohydrate and are physically linked within polysaccharide 71 
utilisation loci (PULs)8,9. Glycan depolymerisation is generally initiated by bacterial surface 72 
endo-acting GHs/PLs, and the oligosaccharides generated imported into the periplasm and 73 
further metabolised9-11.  74 
 75 
A ubiquitous component of the human diet are arabinogalactan proteins (AGPs).  These 76 
proteoglycans are in every taxonomic plant group12, with high concentrations in processed 77 
foods such as red wine and instant coffee13,14. Gum Arabic AGP (GA-AGP) is widely used in 78 
the food industry to improve biophysical properties of many products15. AGPs comprise a 79 
β1,3-galactan backbone with β1,6-galactan side-chains, which contain carbohydrate 80 
decorations (Fig. 1ab). Glycans, comprising 90% of AGPs, are O-linked to hydroxyprolines 81 
in the protein component16. AGP utilisation is poorly understood. Oligosaccharide side-82 
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chains are released by GH43 subfamily 24 (GH43_24) exo-acting β1,3-galactanases17, 83 
however, the mechanism for their unusual substrate specificity remains unclear. Although 84 
endo-acting enzymes contribute to glycan degradation, the role of endo-galactanases in 85 
AGP metabolism is unknown. While some enzymes that target AGPs have been 86 
described18,19, models for the degradation of these glycoproteins are lacking. The prebiotic 87 
potential of GA-AGPs is evident20, however, fulfilling the health benefit of these glycans 88 
requires a deeper understanding of how these proteoglycans are metabolised by the HGM. 89 
 90 
Here we report a model for simple and complex AGP utilisation by Bacteroides species of 91 
the HGM. We reveal mechanisms of substrate specificity and catalysis of exo-acting β1,3-92 
galactanases. Strategies for removing the L-rhamnopyranose (Rhap) cap of complex AGPs 93 
were shown to influence synergetic interactions between side-chain degrading GHs and 94 
PLs. Critically, the cellular location of the endo-β1,3-galactanase defined whether a 95 
bacterium was a keystone organism, or a recipient of AGP-derived oligosaccharides.   96 
 97 
Results 98 
 99 
Functional significance of PULAGPS and PULAGPL in B. thetaiotaomicron. Previous data 100 
identified two PULs (PULAGPL and PULAGPS) upregulated when Bacteroides thetaiotaomicron 101 
was cultured on larchwood AGP (LA-AGP) (Fig. 1ac)21. Here we showed that only PULAGPS 102 
was substantially activated by GA-AGP (Supplementary Fig. 1a), suggesting that different 103 
molecules activate the two PULs. Growth studies of mutants of B. thetaiotaomicron lacking 104 
the two AGP PULs showed that ΔPULAGPL failed to grow on LA-AGP but displayed growth on 105 
GA-AGP treated with endo-β1,3-galactanases (Supplementary Fig. 2). ΔPULAGPS grew on 106 
LA-AGP but poorly on treated GA-AGP (Supplementary Fig. 2). These data suggest that 107 
the two PULs orchestrate the degradation of different AGPs. To explore the biochemical 108 
basis for these phenotypes, the specificity of the enzymes encoded by these loci were 109 
determined (Supplementary Table 1). Models for metabolism of selected AGPs were 110 
generated (Fig. 1ab).  111 
 112 
Cleavage of the galactan backbone. Known activities within GH families the β-1,3-galactan 113 
backbone is depolymerized by GH43 subfamily 24 (GH43_24)22 and/or GH1623 enzymes.  114 
Thus, activity of B. thetaiotaomicron GH43_24 enzymes [BT0264, BT0265, BT3683 (also 115 
contains a GH16 module) and BT3685] encoded by PULAGPL and PULAGPS were evaluated 116 
against D-galactose (Gal) disaccharides, LA-AGP, GA-AGP, and linear β-1,3-galactan. 117 
Based on activity against disaccharides (Supplementary Table 2), and an active site pocket 118 
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(BT3683 and BT0265) in which O3 of bound Gal was not solvent exposed (Fig. 3cd), 119 
BT0265, BT3683 and BT3685 are exo-acting β-1,3-galactosidases. BT0265 and BT3683 120 
were active against LA-AGP and GA-AGP releasing oligosaccharide side-chains (Fig. 121 
2abc). Mutational analysis (Supplementary Table 3) showed that only the GH43_24 122 
module contributed to the observed activity of BT3683.  Consistent with other GH43_24 β-123 
1,3-galactosidases17, the oligosaccharides generated by BT0265 and BT3683 likely 124 
comprise β-1,6-galactooligosaccharide side-chains. This assumption suggests that in 125 
BT0265 and BT3683, O6 of the Gal backbone units bound in the active site were solvent 126 
exposed enabling side-chain accommodation. BT3685 was more active against β-1,3-127 
galactobiose than the other GH43_24 enzymes, but was inactive against the AGPs tested. 128 
The role of the enzyme in degrading AGPs is unclear. The GH43_24 enzyme BT0264 was 129 
inactive against galactobiose, released oligosaccharides from LA- and GA-AGP, and  130 
generated a range of oligosaccharides from β1,3-galactan with the smaller products 131 
increasing with time (Fig. 2d); consistent with endo-activity. 132 
 133 
Synergistic interactions in the degradation of the β-1,3-galactan backbone. In addition 134 
to O6-linked side chains, the AGP backbones contain sugar pendants at O2 or O4, 135 
commonly β-L-Araf units. These substitutions block progression of the exo-β1,3-136 
galactanases through  steric constraints (Fig. 3). Mechanisms for relieving these 137 
“roadblocks” include removal of these decorations and/or endo-cleavage of the backbone 138 
creating non-reducing termini downstream of O2/O4 decoration. To explore these 139 
hypotheses GA- and LA-AGP were incubated with BT3674, which contains an active-site 140 
typical of β-L-arabinofuranosidases (Supplementary Fig. 3). The enzyme released 141 
arabinose from LA-AGP, mediating an eight-fold increase in oligosaccharides generated by 142 
the exo-β1,3-galactanases (Fig. 2a). The endo-β1,3-galactanase BT0264 also increased the 143 
activity of the exo-β1,3-galactanases  (Fig. 2bc). Thus, B. thetaiotaomicron exploits two 144 
mechanisms to reduce stalling of exo-β1,3-galactanases.  145 
 146 
Crystal structures of GH43_24 enzymes. The crystal structures of BT0265 and BT3683 147 
revealed that both exo-β-1,3-galactosidases displayed a five-bladed β-propeller fold (Fig. 3a) 148 
typical of GH43 enzymes24. Typical of GH43 exo-glycosidases the active-site pocket of 149 
BT0265 and BT3683 is in the centre of the β-propeller24. Ligand complexes revealed the 150 
polar interactions between Gal, hexasaccharide product and Gal-based inhibitors and the 151 
exo-β-1,3-galactosidases, Fig. 3bcd. These polar interactions are augmented by apolar 152 
contacts with a hydrophobic platform (Trp261/Trp213 in BT3683/BT0265). Interaction of the 153 
essential glutamate, Glu86/Glu87 in BT0265/BT3683 (Supplementary Table 3), with the 154 
5 
 
axial O4 of Gal (Fig. 3bd) confers selectivity for Gal over Glc, and is thus a key specificity 155 
determinant. O3 of bound ligands points into the active site pocket explaining the exo- and 156 
not endo-activity of the β1,3-galactanases. The lack of interactions with substrate outside of 157 
the active site indicates that complementarity of the helical conformation of β1,3-galactan25 158 
and topology of the catalytic centre drives specificity.  159 
 160 
The BT0265 hexasaccharide product complex reveals O6 of Gal in the active site is solvent 161 
exposed (Fig. 3b). This explains why the enzyme releases backbone Gal residues 162 
decorated with oligosaccharides appended at O6. Whether side-chains contribute to 163 
specificity is unclear; however, elements of these decorations interact with BT0265 (Fig. 3b),  164 
 165 
In GH43 enzymes the catalytic acid (glutamate) and pKa modulator (aspartate) are 166 
invariant24. The assignment of Glu240 in BT3683 as the catalytic acid (Fig. 3d) is supported 167 
by the reactivity of E240A. This variant did not hydrolyse β1,3-galactobiose but hydrolysed 168 
2,4-dinitrophenyl-β-D-Gal (Supplementary Table 3), consistent with requiring protonation 169 
when Gal is the leaving group but not when 2,4-dinitrophenolate (pKa 3.6) is generated. 170 
Mutation of the catalytic acid in BT3685 (E225Q) also revealed the expected impact on 171 
activity against the two substrates. GH43_24 enzymes lack the aspartate catalytic base that 172 
is invariant in other GH43 subfamilies24. In GH43_24 a highly conserved glutamine binds a 173 
water molecule (Fig. 3d) that could attack the anomeric carbon of the substrate below the 174 
plane of the ring, consistent with the inverting mechanism of BT3685 (Supplementary Fig. 175 
4). Mutation of the glutamine in BT3683 supports a catalytic role for this residue 176 
(Supplementary Table 3). The glutamine may form an imidic acid through tautomerization 177 
and thus function as the base, as proposed for some inverting enzymes26, or assist in 178 
positioning the catalytic water that attacks the anomeric centre of the substrate.  179 
 180 
Deconstruction of the AGP side chains. The side-chains, released by exo-β1,3-181 
galactosidases from GA-AGP were characterized by mass spectrometry (Supplementary 182 
Fig. 5) and NMR spectroscopy (Supplementary Fig. 6). The major side chains comprised 183 
oligosaccharides with a degree of polymerization (DP) of 3 to 7 (Supplementary Fig. 5). 184 
The non-reducing terminus of each oligosaccharide comprised Rhap-α1,4-GlcA-β1,6-Gal. 185 
Previous studies showed that the B. thetaiotaomicron GH145 α-L-rhamnosidase BT3686 186 
removed Rhap exposing GlcA19.  Here we show that the exposed GlcA was removed by the 187 
β-glucuronidase BT3677, the founding member of GH154 (Fig. 4, Supplementary Fig. 7a, 188 
Supplementary Table 2). BT3677 was only active against oligosaccharides after removal of 189 
the terminal Rhap, and is thus exo-acting. The β-glucuronidase hydrolysed the GlcA-β1,6-190 
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Gal linkage when Gal was substituted with α-L-Ara at O3 (Fig. 4) but not at O4 191 
(Supplementary Fig. 8). 192 
 193 
B. thetaiotaomicron removes the terminal disaccharide structure of GA-AGP by a 194 
rhamnosidase-glucuronidase (RG) pathway, consistent with limited growth of Δbt3686 on 195 
GA-AGP (Supplementary Fig. 2b). Cell-free extracts of Δbt3686 cultured on LA-AGP failed 196 
to release Rhap from GA-AGP. These data confirm the RG pathway operates in B. 197 
thetaiotaomicron and that the side chains in GA-AGP are extensively capped with Rhap. The 198 
orthologues of BT3686 in B. cellulosilyticus, and other HGM Bacteroidetes species are not 199 
functional rhamnosidases as they lack the catalytic histidine19. B. cellulosilyticus, however, 200 
contains a rhamno-glucurono lyase (BACCELL_00875) that cleaved the Rha-α1,4-GlcA 201 
linkage, and the resultant 4,5ΔGlcA was released by an unsaturated glucuronidase18. Thus, 202 
B. cellulosilyticus releases the capping Rha-GlcA disaccharide through a lyase-unsaturated 203 
glucuronidase (LU) pathway.  Genomic studies indicate that both routes to removing the 204 
capping disaccharide (RG and/or LU pathways) are possible in some Bacteroidetes species. 205 
The significance of deploying both pathways is discussed below. 206 
 207 
Gal at the base of AGP β-1,6-galactan side-chains can be decorated with Araf that may be 208 
capped with α-Gal. No enzyme encoded by B. thetaiotaomicron AGP PULs removed the α-209 
Gal (discussed below). PULAGPS also encodes two arabinofuranosidases; a GH43 enzyme 210 
(BT3675) and the non-specific arabinofuranosidase, BT3679, active against wheat AGP 211 
(WH-AGP), arabinoxylan and sugar beet arabinan (Supplementary Fig. 7b, 212 
Supplementary Table 2). BT3679 establishes a GH family (GH155) exclusive to the 213 
Bacteroidetes phylum. Cleavage of 4-nitrophenyl-α-L-arabinofuranoside by BT3679 in the 214 
presence of methanol generated methyl-α-arabinofuranoside (Supplementary Fig. 7c), 215 
demonstrating a retaining mechanism. In GA-AGP BT3679 cleaved the Araf-α1,3-Gal 216 
linkage at the base of the β1,6-galactan backbone irrespective of whether the Gal was 217 
decorated at O4 (Supplementary Fig. 8). BT3675 hydrolysed the Araf-α1,3-Gal glycosidic 218 
bond, but not when Gal also contained α-L-Araf at O4. The two enzymes and cell-free 219 
extracts of B. thetaiotaomicron cultured on AGPs did not cleave the O4-linked Araf. Thus, B. 220 
thetaiotaomicron is unable to cleave α-Araf linked O4 to Gal.  221 
    222 
The GH35 enzyme BT0290 hydrolysed β-1,6-galactan side-chains in LA-AGP and β-1,6-223 
galactobiose, exhibiting minor activity against β-1,3-galactobiose. The crystal structure of 224 
BT0290 revealed a (β/α)8 barrel catalytic module. In the ligand complex Gal is in the active 225 
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site pocket at the end of the β-barrel (Supplementary Fig. 9), which contains a pair of 226 
glutamates that comprise a canonical catalytic apparatus for a retaining enzyme, expected 227 
for GH35. The pocket extends onto a planar surface that houses the O6-linked β-Gal in the 228 
+1 subsite. Trp215 in the +1 subsite creates a steric block for O3- or O4-linked sugars and 229 
provides a hydrophobic platform for an O6-linked β-Gal. This tryptophan is likely a specificity 230 
determinant for the β-1,6-galactosidase activity of BT0290.  231 
 232 
In vivo degradation of AGPs by HGM Bacteroidetes species. Supplementary Table 4 233 
reports growth profiles of type strains of 20 HGM Bacteroidetes species. All species except 234 
Dysgonomonas gadei utilised LA-AGP, while only B. cellulosilyticus, B. caccae and D. gadei 235 
grew on GA-AGP or WH-AGP (Supplementary Table 4).  This was surprising as B. 236 
thetaiotaomicron, at least, degrades side-chains from GA-AGP. The initial depolymerisation 237 
of polysaccharides in Bacteroides species occurs at the bacterial surface, generating 238 
oligosaccharides suitable for transport into the periplasm10,11. In B. thetaiotaomicron the 239 
GH43_24 endo-β1,3-galactanase, BT0264, has a type I signal peptide typical of periplasmic 240 
proteins, confirmed by cell localization studies (Fig. 5a, Supplementary Fig. 10). The 241 
inability of B. thetaiotaomicron to grow on GA-AGP likely reflects the absence of a surface 242 
endo-β1,3-galactanase required to generate the GA-AGP-derived oligosaccharides for 243 
import into the periplasm. This was confirmed by growth of B. thetaiotaomicron on GA-AGP 244 
and WH-AGP pre-treated with BT0264 (Fig. 5bc, Supplementary Table 4). The BT0264-245 
treated GA-AGP was also a growth substrate for the other 16 Bacteroidetes species unable 246 
to utilise intact GA- and WH-AGP (Supplementary Table 4). The inability of the majority of 247 
HGM-derived Bacteroidetes species to utilise GA-AGP reflects the lack of an endo-β1,3-248 
galactanase that can degrade extracellular GA-AGP. Growth of these organisms on LA-AGP 249 
reflects the low DP of the glycan, enabling direct import into the periplasm.  250 
 251 
The B. cellulosilyticus genome encodes four GH16 and four GH43_24 enzymes that, 252 
potentially, comprise endo-β1,3-galactanases. RT-PCR of SusC genes of three PULs 253 
encoding enzymes from these families (Supplementary Fig. 1b), revealed only one locus 254 
(contains three susCs) that was significantly upregulated by AGPs (Supplementary Fig. 255 
1c). Of the GH43_24 and GH16 enzymes encoded by these PULs, only Baccell00844 256 
(GH16) degraded β1,3-galactan and is thus an endo-β1,3-galactanase (Fig. 5d).  Baccell-257 
00844 contains a type II signal peptide, consistent with a surface location. Whole cell assays 258 
of B. cellulosilyticus under aerobic conditions, which report only activity of surface proteins11, 259 
showed that β1,3-galactan was degraded into numerous oligosaccharides (Fig 5e). This 260 
indicates that B. cellulosilyticus displays surface endo-β1,3-galactanase activity, which is 261 
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likely mediated by Baccell00844. Support for the role played by Baccell00844 is provided by 262 
growth of all the Bacteroidetes species on GA-AGP pre-treated with Baccell00844 263 
(Supplementary Table 4). An orthologue to Baccell00844 in B. caccae (BACCAC_03237) 264 
may explain its growth on GA-AGP and WH-AGP. Insertion of baccell00844 into B. 265 
thetaiotaomicron PULAGPL (B. thetaiotaomicron::baccell00844) enabled the bacterium to 266 
grow on intact GA-AGP and WH-AGP (Fig. 5bc). B. thetaiotaomicron::baccell00844, but not 267 
wild type B. thetaiotaomicron, degraded β1,3-galactan in aerobic whole cell assays (Fig. 5e) 268 
demonstrating acquisition of surface endo-β1,3-galactanase activity. Proteomic analysis of 269 
intact cells of B. thetaiotaomicron::baccell00844 revealed tryptic peptides from 46 proteins 270 
(Fig 5f) that were detected only on the bacterial surface. These proteins included Baccell-271 
00844 (five tryptic peptides identified by MS/MS, Supplementary Fig. 11). Among the 45 B. 272 
thetaiotaomicron proteins were a number that have been shown, experimentally, to be 273 
surface exposed (SusD/C-like proteins, surface CAZymes and SGBPs; Supplementary 274 
Table 5), and all the polypeptides contain canonical type II signal peptides consistent with 275 
outer membrane attachment. The presence of Baccell00844 among these 46 proteins 276 
supports its proposed surface location in B. thetaiotaomicron::baccell00844. Collectively, the 277 
proteomics data and surface endo-β1,3-galactanase activity of B. 278 
thetaiotaomicron::baccell00844 demonstrates that growth of the engineered bacterium on 279 
intact GA-AGP and WH-AGP is conferred through the surface endo-β1,3-galactanase 280 
activity encoded by baccell00844.  281 
 282 
Data presented above suggest B. thetaiotaomicron::baccell_00844, in addition to B. 283 
cellulosilyticus, B. caccae and D. gadei are keystone organisms for AGP utilisation by 284 
Bacteroidetes. To test this hypothesis two of the organisms that cannot grow on untreated 285 
GA-AGP, wild type B. thetaiotaomicron and B. ovatus, were co-cultured with B. 286 
thetaiotaomicron::baccell_00844, B. cellulosilyticus and B. caccae on the intact glycan, and 287 
the bacteria in the co-cultures were quantified by quantitative-PCR of genomic-specific 288 
sequences. CFUs of wild type B. thetaiotaomicron and B. ovatus increased (Fig. 6) and thus 289 
these organisms grew on GA-AGP in the presence, but not in the absence, of B. 290 
cellulosilyticus, B. caccae or B. thetaiotaomicron::baccell_00844. This indicates that B. 291 
cellulosilyticus, B. thetaiotaomicron::baccell_00844 or B. caccae provide GA-AGP-derived 292 
oligosaccharides as growth substrates for the recipient bacteria. These data establish B. 293 
cellulosilyticus, B. thetaiotaomicron::baccell_00844 and B. caccae, and by inference D. 294 
gadei, as keystone bacteria in the utilisation of complex AGPs, with B. thetaiotaomicron, B. 295 
ovatus, and likely other Bacteroidetes, comprising recipient organisms. B. thetaiotaomicron 296 
and B. ovatus demonstrate a preference for products released by B. cellulosilyticus and B. 297 
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caccae, respectively, providing possible examples of discrete AGP cross-feeding niches 298 
provided by each keystone organism.   299 
 300 
To establish the extent to which B. thetaiotaomicron utilizes AGP side-chains, limit products 301 
generated from growth on BT0264-treated GA-AGP were characterized. The major product 302 
was a hexasaccharide derived from a heptasaccharide in which the terminal rhamnose had 303 
been removed by BT3686 (Supplementary Fig. 12 and 13). The inability to degrade this 304 
oligosaccharide reflects the absence of a α-galactosidase encoded by the AGP-PULs, 305 
preventing BT3679 from accessing the 3-linked Araf. The limit product generated by B. 306 
cellulosilyticus from GA-AGP was a tetrasaccharide, also derived from the heptasaccharide 307 
(Supplementary Fig. 12 and 13). This is consistent with the α-galactosidase gene 308 
baccell00859 in the B. cellulosilyticus AGP PUL, and removal of the Rha-GlcA cap by the LU 309 
pathway in which the unsaturated glucuronidase can target 4,5ΔGlcA-β1,6-Gal linkages in 310 
which the Gal is decorated at O3 and/or O4. Both organisms lacked an α-311 
arabinofuranosidase that targeted O4 linkages. 312 
 313 
Analysis of AGP-PULs in HGM Bacteroidetes species. Only B. finegoldii contained a 314 
locus equivalent to B. thetaiotaomicron PULAGPL, while PULAGPs was in most species of the 315 
Bacteroides genus, with various levels of rearrangements (Supplementary Fig. 14 and 15). 316 
No  enzyme conservation pattern that correlated with growth on LA-AGP or GA-AGP was 317 
identified. For example, B. stercoris grows on LA-AGP but lacks the orthologous enzymes 318 
found in its closest relatives. The evolution of AGP-PULs was compared to the (16S-based) 319 
phylogenetic tree of the species (Supplementary Table 4). Closely-related species have 320 
similar PUL organization, but at the single gene level there are examples of a lack of 321 
orthologues. Thus Bacteroidetes AGP PULs are highly dynamic systems that can be rapidly 322 
lost, gained, or rearranged between closely related species (see B. massiliensis and B. 323 
plebeius in comparison with B. vulgatus and B. dorei; B. cellulosilyticus compared to B. 324 
thetaiotaomicron). In consequence 16S-derived taxonomy cannot be used to predict AGP 325 
degradation in Bacteoidetes. 326 
  327 
Discussion 328 
This study reveals the enzymes required to depolymerise the β1,3-galactan backbone of 329 
AGPs, resulting in release of the oligosaccharide side-chains. This diversity likely reflects the 330 
substituents at O2 or O4 of the backbone Gals that would limit the progressive action of the 331 
critical exo-galactanases. The data also show that the GH43 exo-β1,3-galactanases lack the 332 
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catalytic base present in all other enzymes of this family. Deviation from conservation of 333 
catalytic residues in GH families is rare, although not without precedent27. 334 
 335 
Analysis of the enzymes that deconstruct side-chains of two AGPs provides insights into the 336 
biological relevance of the AGP PULs in B. thetaiotaomicron. The inability of ΔPULAGPL to 337 
grow on LA-AGP reflects the absence of BT0290, the β1,6-galactosidase that hydrolyses the 338 
β1,6-galactan side-chains which, in this glycan, are not extensively decorated. BT0290 is 339 
less important in degrading complex AGPs, such as GA-AGP, as the decoration of β1,6-340 
galactan side-chains with other sugars represent significant nutrients. The inability of 341 
ΔPULAGPS to grow on GA-AGP (endo-β1,3-galactanase pre-treated) reflects extensive 342 
capping of the side chains with Rhap. Loss of the rhamnosidase gene bt3686 in PULAGPS 343 
greatly restricts further degradation of the side-chains. To summarise, PULAGPS encodes an 344 
enzyme consortium that degrades the major side chains in complex AGPs such as GA-AGP, 345 
while PULAGPL targets the β-1,6,linked Gal side chains that are important nutrients in simpler 346 
glycans such as LA-AGP.  347 
 348 
AGPs are diverse and numerous enzymes are required to mediate their deconstruction. 349 
Combined with recent reports18,19, four CAZyme families that contribute to AGP degradation 350 
were discovered, however, further enzymes likely await discovery. Indeed, in PULAGPL there 351 
are 14 genes encoding secreted hypothetical proteins that may contribute to degradation of 352 
complex AGPs not investigated here. Unusually, two different pathways remove the 353 
disaccharide that caps the side-chains in GA-AGP. Although the more flexible LU pathway 354 
should enable more comprehensive degradation, several HGM Bacteroides species utilise 355 
the RG pathway that limits downstream processing of the oligosaccharides. The contrasting 356 
oligosaccharide utilisation profiles observed between B. thetaiotaomicron and B. 357 
cellulosilyticus (Supplementary Fig. 11), and predicted by differences in the AGP PULs in 358 
other Bacteroides spp. (Supplementary Fig. 12 and 13), may enable co-existence of 359 
species within a common niche targeting different components of the same glycan. 360 
 361 
The majority of Bacteroidetes species studied here were unable to utilise GA-AGP, although 362 
they grow on the glycan after backbone cleavage. Utilisation of complex AGP by the HGM 363 
Bacteroidetes relies on the extracellular endo-activity of a few keystone  species.  This study 364 
in conjunction with recent reports28,29 shows that glycan cross-feeding between HGM 365 
Bacteroides species contributes to the ecology of carbohydrate utilisation in this ecosystem. 366 
Nevertheless Bacteroides glycan degrading systems generally contain surface endo-acting 367 
11 
 
enzymes that generate fragments which are imported into the periplasm10,11, obviating the 368 
requirement for cross-feeding to utilise the polysaccharide.  369 
 370 
In conclusion, dissecting mechanisms by which AGPs are degraded by HGM Bacteroidetes 371 
species reveals enzyme families of potential biotechnological relevance, and shows how 372 
synthetic biology can be used to engineer organisms to degrade AGPs that are abundant in 373 
the human diet.  374 
 375 
 376 
METHODS 377 
 378 
Cloning, expression and purification of recombinant proteins 379 
DNAs encoding enzymes lacking their signal peptides were amplified by PCR using 380 
appropriate primers. The amplified DNAs were cloned into pET28a with an N-terminal His6 381 
tag using NheI and XhoI restriction sites (Table 3SM). The genes were then expressed in E. 382 
coli BL21, or Tuner cells, transformed with the appropriate recombinant plasmids. The 383 
transformed E. coli strains were cultured in Luria broth (LB) supplemented with 10 μg/ml of 384 
kanamycin. Cultured cells were grown at 37 °C to mid-log phase and induced with 1 mM 385 
isopropyl β-D-1-thiogalactopyranoside at 16 °C overnight. Cells were pelleted by 386 
centrifugation at 5,000 rpm for 10 min and resuspended in 20 mm Tris-HCl buffer, pH 8.0, 387 
containing 300 mm NaCl. For selenomethionine-derivatized protein the above procedure 388 
was used but adjusted as follows: E. coli B834 cells were transformed with the appropriate 389 
recombinant plasmid. Overnight 5-ml cultures, in LB, were then used to inoculate 100 ml of 390 
LB culture in a 250-ml flask, which was then grown to an O.D. of 0.4. A methionine-deficient 391 
media was prepared using the Molecular Dimensions SelenoMetTM Medium Base (MD12-392 
501) and SelenoMetTM Nutrient mixtures (MD12-502) and was used to wash the cultured 393 
B834 cells. The cells were then inoculated into 1 liter of methionine-deficient media to which 394 
selenomethione was added to a final concentration of 5 mg/ml. Cells were collected and 395 
disrupted by sonication, and the cell-free extract was recovered by centrifugation at 15,000 396 
rpm for 30 min. Recombinant proteins were purified from the cell-free extract using 397 
immobilized metal affinity chromatography using TalonTM, a cobalt-based matrix. Proteins 398 
were eluted from the column in Buffer A containing 100 mm imidazole. For crystallographic 399 
studies, BT0265, BT0290, BT3674, BT3679, and BT3683 were further purified by size 400 
exclusion chromatography using a Superdex S200 16/600 column equilibrated with Buffer A 401 
on a fast protein liquid chromatography system (ÄKTA FPLC; GE Healthcare). All proteins 402 
were purified to electrophoretic homogeneity as judged by SDS-PAGE. 403 
 404 
Mutagenesis 405 
Site-directed mutagenesis was conducted using the PCR-based QuickChange site-directed 406 
mutagenesis kit (Strategene) according to the manufacturer’s instructions, using the 407 
appropriate plasmid encoding BT0290, BT3674, BT3683 and BT3685 as the template and 408 
appropriate primer pairs. 409 
 410 
 411 
Large scale purification of oligosaccharides 412 
GA-AGP derived oligosaccharides were generated by incubating 20 g of the glycan with 1 413 
µM of the β1,3-galactosidase BT0265 in 20 mM sodium phosphate buffer pH 7.0 414 
implemented with 150 mM NaCl at 37 oC for 16 h. The oligosaccharide mixture was freeze 415 
dried and resuspended in water before being applied to a P2-BioGel (BioRad) column with a 416 
0.22 ml/min flow rate. Fractions were evaluated for oligosaccharide content and purity by 417 
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TLC. Pure fractions of defined oligosaccharides were pooled and concentrated. 418 
Oligosaccharide size was confirmed by Mass Spectrometry and HPAEC.  419 
 420 
Chemical synthesis 421 
The synthesis of 2,4-dinitrophenyl-β-D-galactopyranoside was as described previously31  422 
 423 
(5R,6S,7S,8R)-5-[(Benzyloxy)methyl]-6,7,8-tri(benzyloxy)-5,6,7,8-424 
tetrahydroimidazo[1,2-a]pyridine 425 
 5-Amino-2,3,4,6-tetra-O-benzyl-5-deoxy-1-thio-D-galactono-1,5-lactam32 426 
(61.5 mg, 0.111 mmol) was dissolved in aminoacetaldehyde dimethyl acetal (0.18 mL, 1.652 427 
mmol) and stirred under N2 for 24 h. The mixture was diluted with EtOAc (20 mL) and 428 
washed with H2O (2 × 20 mL) and brine (1 × 20 mL). The organic extracts were dried 429 
(MgSO4) and then concentrated under reduced pressure. The crude residue was dissolved 430 
in toluene (3.2 mL) and H2O (0.3 mL). p-Toluenesulfonic acid monohydrate (54.9 mg, 0.289 431 
mmol) was added to the solution and the reaction mixture was stirred at 65 °C for 18 h. The 432 
mixture was diluted with EtOAc (20 mL) and washed with NaHCO3 (2 × 20 mL) and brine (1 433 
× 20 mL). The organic extracts were dried (MgSO4), concentrated and the resulting residue 434 
was subjected to flash chromatography (EtOAc/pet. spirits 8:2) to afford the protected 435 
galactonoimidazole (49.1 mg, 79% over two steps) as a colourless oil; [α]D26 +73 (c 1.36, 436 
CHCl3); 1H NMR (500 MHz, CDCl3): δ 3.74 (1 H, dd, J5,6 = 10.2, J6,7 = 8.3 Hz, H6), 4.02 (2 H, 437 
m, H8, H7), 4.34 (1 H, dd, J5,5’ = 1.9, J5’,5’ = 5.8 Hz, CH2(C5)), 4.44 (3 H, m, CH2(C5), H5, 438 
CH2Ph), 4.55 (2 H, m, 2 × CH2Ph), 4.62 (2 H, m, 2 × CH2Ph), 4.71 (2 H, m, 2 × CH2Ph), 4.90 439 
(1 H, d, J = 11.9 Hz, CH2Ph), 7.03 (1 H, d, J2,3 = 1.3 Hz, H3), 7.14 (1H, d, J2,3 = 1.3 Hz, H2), 440 
7.18-7.32 (20 H, m, 4 × Ph); 13C NMR (125 MHz, CDCl3): δ 57.5 (1 C, C5), 71.5 (1 C, 441 
CH2Ph), 71.7 (1 C, C7), 72.0 (1 C, C6), 71.4 (1 C, CH2Ph), 72.9 (1 C, CH2Ph), 73.5 (1 C, 442 
CH2Ph), 73.7 (1 C, C5’), 77.6 (1 C, C8), 119.5 (1 C, C2), 129.2 (1 C, C3), 127.7-138.4 (20 C, 443 
4 × Ph), 142.1 (C8’) ppm; HRMS (ESI)+ m/z 561.2751 [C36H36N2O4 (M+H)+ requires 444 
561.2748]. 445 
(5R,6S,7S,8R)-5-[(Hydroxymethyl]-6,7,8-triol-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine 446 
(Galacto-imidazole; Gal-Im) 447 
Pd(OH)2/C (20%, 46.2 mg) was added to a solution of EtOAc/MeOH/H2O 448 
(5:17:3, 1.0 mL), AcOH (0.44 mL) and the protected imidazole (24.6 mg, 0.044 mmol). The 449 
reaction vessel was filled with H2 (34 bar) and agitated for 41 h. The suspension was filtered 450 
through a Celite pad and subjected to flash chromatography (EtOAc/MeOH/H2O 8:2:1) to 451 
afford the target (8.5 mg, 96%) as an amorphous solid; m.p. 82 °C; [α]D23 +22 (c 0.435, 452 
MeOH); 1H NMR (500 MHz, CD3OD): δ 3.88 (1 H, dd, J6,7 = 2.2, J7,8 = 7.7 Hz, H7), 4.05 (2 H, 453 
apt. d, CH2(C5)), 4.28 (1 H, m, H5), 4.38 (1 H, dd, J5,6 = 3.4, J6,7 = 2.2 Hz, H6), 4.82 (1 H, d, 454 
J2,3 = 7.7 Hz, H8), 7.19 (1 H, d, J = 1.1 Hz, H3), 7.51 (1H, d, J = 1.2 Hz, H2); 13C NMR (125 455 
MHz, CD3OD): δ 61.6 (1 C, C5), 63.1 (1 C, C5’), 67.7 (1 C, C8), 70.5 (1 C, C6), 75.0 (1 C, 456 
C7), 119.9 (1 C, C2), 126.4 (1 C, C3), 147.6 (C8’) ppm. 457 
CAZyme Assays 458 
Spectrophotometric quantitative assays for β-D-galactosidase BT0264, BT0290, BT3683 and 459 
BT3685; β-L-arabinofuranosidase BT3674; α-L-arabinofuranosidases BT3675 and BT3679 460 
and the β-D-glucuronidase BT3677 were monitored by the formation of NADH, at A340 nm 461 
using an extinction coefficient of 6,230 M−1 cm−1, with an appropriately linked enzyme assay 462 
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system. The assays were adapted from two Megazyme International assay kits; the L-463 
arabinose/D-galactose assay kit (K-ARGA) and the α-glucuronidase assay kit (K-AGLUA). 464 
Activity on 4-nitrophenyl-glycosides was monitored at A400nm. The mode of action of enzymes 465 
were determined using high performance anion exchange chromatography (HPAEC) or TLC, 466 
as appropriate. In brief, aliquots of the enzyme reactions were removed at regular intervals 467 
and, after boiling for 10 min to inactivate the enzyme and centrifugation at 13,000g, the 468 
amount of substrate remaining or product produced was quantified by HPAEC using 469 
standard methodology. The reaction substrates and products were bound to a Dionex 470 
CarboPac PA100 (galactooligosaccharides/arabinooligosaccharides), PA1 471 
(monosaccharides) or PA20 (polygalacturonic acid oligosaccharides) column and glycans 472 
eluted with an initial isocratic flow of 100 mM NaOH then a 0–200 mM sodium acetate 473 
gradient in 100 mM NaOH at a flow rate of 1.0 ml min−1, using pulsed amperometric 474 
detection. Linked assays were checked to make sure that the relevant enzyme being 475 
analysed was rate limiting by increasing its concentration and ensuring a corresponding 476 
increase in rate was observed. A single substrate concentration was used to calculate 477 
catalytic efficiency (kcat/KM), and was checked to be markedly less than KM by halving and 478 
doubling the substrate concentration and observing an appropriate increase or decrease in 479 
rate. The equation V = (kcat/KM)[S][E] where V is the initial rate, [S] and [E] are substrate and 480 
enzyme concentration, respectively. All reactions were carried out in 20 mM sodium 481 
phosphate buffer, pH 7.0, with 150 mM NaCl (defined as standard conditions) and performed 482 
in at least technical triplicates. 483 
 484 
Electrospray ionisation mass spectrometry (ESI-MS) 485 
The molecular mass of purified oligosaccharides (in 10 mM ammonium acetate, pH 7.0) 486 
were analysed via negative ion mode infusion/offline ESI-MS following dilution (typically 1:1 487 
(v/v)) with 5% trimethylamine in acetonitrile. Electrospray MS data was acquired using an 488 
LTQ-FT mass spectrometer (Thermo) with a FT-MS resolution setting of 100,000 at 489 
m/z = 400 and an injection target value of 1,000,000. Infusion spray analyses were 490 
performed on 5–10 μl of samples using medium ‘nanoES’ spray capillaries (Thermo) for 491 
offline nanospray mass spectrometry in negative ion mode at 1 kV. 492 
 493 
Liquid chromatography-mass spectrometry 494 
The sample containing the oligosaccharides generated by treatment of LA-AGP with BT0265 495 
was diluted 1:10 (v/v) with Buffer B (85% acetonitrile/15% 50 mM ammonium formate in 496 
water, pH 4.7) and 0.5 µL was analysed by LC-MS analysis via elution from a ZIC-HILIC 497 
(SeQuant®, 3.5 µm, 200Å, 150 X 0.3 mm, Merck, UK) capillary column. The column was 498 
connected to a NanoAcquity HPLC system (Waters, UK) and heated to 35oC with an elution 499 
gradient  as follows; 100% Buffer B for 5 min, followed by a gradient to 25% Buffer B/75% 500 
Buffer A (50 mM ammonium formate in water, pH 4.7) over 40 min. The flow rate was 5 501 
µL/min and 10 column volumes of Buffer B equilibration was performed between injections.  502 
MS data was collected using a Bruker Impact II QTof mass spectrometer operated in 503 
positive ion mode, 50 – 2000 m/z, with capillary voltage and temperature settings of 2800 V 504 
and 200 oC respectively, together with a drying gas flow and nebulizer pressure of 6 L/min 505 
and 0.4 Bar. The MS data was analysed using Compass DataAnalysis software (Bruker). 506 
 507 
1H-NMR determination of catalytic mechanism 508 
The enzymes BT3685 and BT3679 at ~20 μM were assayed using 2,4-dinitrophenyl-β-D-509 
galactopyranoside (5 mM) and 4-nitrophenyl α-L-arabinofuranoside, respectively. The 510 
enzymes were solvent-exchanged three times by ultrafiltration in 20 mM Tris-HCl, 500 mM 511 
NaCl, pD 7.5 using D2O as the solvent. Substrates were repeatedly freeze dried using the 512 
same buffer and resuspended in D2O. Prior to addition of enzyme an initial 1H-NMR 513 
spectrum was obtained. Enzyme was added and spectra were recorded at appropriate time 514 
intervals. The emergence of individual monosaccharide product α- and β-anomers in the 515 
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case of BT3685 was monitored to deduce catalytic mechanism. The reaction catalyzed by 516 
BT3679 was carried out in the presence of 2.5 M methanol. The products were freeze-dried 517 
and resuspended in D2O. Spectra recorded were analysed for the chemical shift of the 518 
anomeric 1H of the methyl L-arabinofuranoside product to determine mechanism.  519 
 520 
2D NMR and mass spectrometry of GA-AGP oligosaccharides 521 
1H-NMR: NMR spectra were recorded at 298 K in D2O with a Bruker AVANCE III 522 
spectrometer operating at 600 MHz equipped with a TCI CryoProbe. NMR chemical-shift 523 
assignments were obtained using 2D 1H-1H TOCSY, ROESY and DQFCOSY alongside 2D 524 
13C HSQC, H2BC, HMBC, HSQC-TOCSY and HSQC-ROESY experiments using 525 
established methods33.  The mixing times were 70 ms and 200 ms for the TOCSY and 526 
ROESY experiments, respectively (data for the tetra- and heptasaccharides are shown in 527 
Supplementary Fig. 4). Chemical shifts were measured relative to internal acetone (δH 528 
=2.225, δC=31.07 ppm). Data were processed using the Azara suite of programs (v. 2.8, 529 
copyright 1993-2017, Wayne Boucher and Department of Biochemistry, University of 530 
Cambridge, unpublished) and chemical-shift assignment was performed using Analysis 531 
v2.434. The non-reducing-end Rha residue was readily identified from the presence of a 532 
methyl group at the 6-position. All the linkages were clear from downfield 13C shifts of the 533 
linked atoms, inter-glycosidic crosspeaks in the HMBC spectrum and intense NOE 534 
crosspeaks in the ROESY spectrum. The anomeric configurations of the pyranoses were 535 
confirmed by measurement of the 1JC-1,H-1 coupling constant (c. 170 and 160 Hz for α- and β-536 
configurations, respectively35) in an F1-coupled 13C HSQC. The assignments were complete 537 
and are shown in Supplementary Table 7. 538 
 539 
Mass spectroscopy: To confirm the AGP oligosaccharide chain structure suggested by 540 
NMR, the sample was per-methylated and analysed by MALDI ToF-MS and MS/MS. A 541 
single high intensity peak, with m/z 1393.5 was identified which is consistent with the 542 
composition Ara2RhaGal3GlcA. The tandem mass spectrometry (MS/MS) spectrum of this 543 
per-methylated oligosaccharide is shown in Supplementary Fig. 5. The presence of Y1 (m/z 544 
259.0) and 1,5X1 (m/z 287.0) indicates the reducing end is Gal. The 0,4A4 (m/z 1217.5) cross-545 
ring fragment indicates the presence of 1,6-linkage onto the reducing end Gal.  Y3 (m/z 546 
1205.5) and 1,5X3 (m/z 1233.4) indicate terminal Rha, Y3α (m/z 1175.4) and 1,5X3a (m/z 547 
1203.4) indicate terminal Gal, and Y2β (m/z 1219.5) and 1,4X2 β (m/z 1247.5) terminal Ara 548 
residues. Y2 (m/z 987.3) indicates a terminal disaccharide Rha-GlcA. The 1,4-linkage 549 
between the terminal Rha and GlcA was confirmed by the cross ring fragments (3,5A2 ion, 550 
m/z 313.0;  0,2X2 ion, m/z 1043.3) and elimination ions (G3 ion, m/z 1157.4;  E2 ion, m/z 551 
399.0). The non-reducing end 0,4A3 cross-ring fragment (m/z 489.0) and H2 elimination ion 552 
(m/z 765.1) suggest the presence of 1,6-linkage between the GlcA and Gal. The 728 Da 553 
mass difference between the Y2 and Y1 ions suggests that there are two Gal and two Ara 554 
residues between the GlcA and the reducing end Gal. The G2 (m/z 807.1) indicates there is 555 
a single backbone residue of Gal. The presence of Y2α ion (m/z 987.3), but absence of an ion 556 
corresponding to loss of a dipentose side chain, indicates that the one of the side chains is a 557 
disaccharide of Gal linked to Ara. As described above, there is terminal Gal, so this structure 558 
is Gal-Ara. Substitution of O3 and O4 but not O2 of the Gal is suggested by the presence of 559 
G2 (m/z 807.1) and 0,2X1, (m/z 315.0), ions. The H2 elimination ion, which reflects loss of 560 
Rha-GlcA and Ara, suggests an Ara is linked to O4 of the Gal, which is supported by the 561 
presence of the 3,5A3 (m/z 677.1).The elimination ions (G2, m/z 807.1; D3, m/z 779.1) suggest 562 
that the Gal-Ara disaccharide is linked to the O3 of the Gal on the backbone. The cross-ring 563 
fragment 0,2X2α (m/z 1071.3) and elimination ion G3α (m/z 1113.3) suggests that the terminal 564 
Gal is not 1,2-linked to the Ara, but we were unable to locate further from the MS/MS the Gal 565 
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linkage, but the results are consistent with 1,3 linkage to the Ara. The presence of this G3α 566 
ion also indicates the furanose form of the Ara.  567 
Growth of Bacteroides and generation of mutants 568 
Bacteroides mutants were generated by deletion of the target gene by counter selectable 569 
allelic exchange using the pExchange-tdk plasmid. The full method is described in Ref36. 570 
Mutants generated in this study are distinguished by the locus tag of the gene 571 
deleted/inactivated (∆btxxx). 572 
  573 
Bacteroides spp. were routinely cultured under anaerobic conditions at 37 °C using an 574 
anaerobic cabinet (Whitley A35 Workstation; Don Whitley) in culture volumes of 0.2, 2 or 575 
5 ml) of TYG (tryptone-yeast extract-glucose medium) or minimal medium (MM)31 containing 576 
0.5-1% of an appropriate carbon source and 1.2 mg ml−1 porcine haematin (Sigma-Aldrich) 577 
as previously described10. The growth of the cultures was monitored by OD600 nm using a 578 
Biochrom WPA cell density meter for the 5 ml cultures or a Gen5 v2.0 Microplate Reader 579 
(Biotek) for the 0.2 and 2 ml cultures. 580 
 581 
Protein cellular localization of BT0264 using antibodies 582 
Cellular localization of proteins was carried out as described previously37. In brief, B. 583 
thetaiotaomicron was grown overnight (OD600 nm value of 2.0) in 5 ml MM containing LA-584 
AGP. The next day, cells were collected by centrifugation at 5,000g for 10 min and 585 
resuspended in 2 ml PBS. Proteinase K (0.5 mg ml−1 final concentration) was added to 1 ml 586 
of the suspension and the other half left untreated (control). Both samples were incubated at 587 
37 °C for 16 h followed by centrifugation (5,000g for 10 min) to collect cells. To eliminate 588 
residual proteinase K activity, cell pellets were resuspended in 1 ml of 1.5 M trichloroacetic 589 
acid and incubated on ice for 30 min. Precipitated mixtures were then centrifuged (5,000g, 590 
10 min) and washed twice in 1 ml ice-cold acetone (99.8%). The resulting pellets were 591 
allowed to dry in a 40 °C heat block for 5 min and dissolved in 250 μl Laemmli buffer. 592 
Samples were heated for 5 min at 98 °C and mixed by pipetting several times before 593 
resolving by SDS–PAGE using 12% gels. Electrophoresed proteins were transferred to 594 
nitrocellulose membranes by western blotting followed by immunochemical detection using 595 
primary rabbit polyclonal antibodies (Eurogentec) generated against BT0264 and secondary 596 
goat anti-rabbit antibodies (Santa Cruz Biotechnology).  597 
 598 
Proteomics 599 
Cell surface shaving: Bacteriodes cell surface digestion was performed as previously 600 
described48, with minor modifications. Briefly, Bacteriodes cells were harvested by 601 
centrifugation (3500 g, 15 min, 4 °C) and washed three times with PBS pH 7.4. Cell pellets 602 
were subsequently resuspended in surface shaving buffer (PBS pH 7.4 containing 0.25 M 603 
Sucrose). Surface shaving was performed using 2 µg trypsin at 37 °C for 30 min with 604 
shaking at 300 rpm.  Cells in surface shaving buffer without trypsin served as controls. After 605 
surface shaving, the cells were pelleted by centrifugation (10000 g, 10 min, room 606 
temperature), and the supernatants were filter-sterilized using 0.22 µm spin filters (Corning 607 
Incorporated). Sterilized supernatants were subsequently incubated for an additional 16 608 
hours at 37 °C for complete digestion. Trypsin digestion was stopped with the addition of 609 
trifluoroacetic acid (TFA) at a final concentration of 1%, and peptides were desalted using 610 
Macro C18 Spin Columns (Harvard Apparatus).  611 
Whole-cell lysate preparation: Bacteriodes cells were harvested and washed as described 612 
above. Cell pellets were subsequently resuspended in 8 M urea buffer in 50 mM 613 
triethylammonium bicarbonate (TEAB), containing 5mM tris(2-carboxyethyl)phosphine. Cells 614 
were lysed via sonication using an ultrasonic homogenizer (Hielscher). Proteins were 615 
subsequently alkylated for 30 min at room temperature using 10 mM iodoacetamide in the 616 
dark. Protein concentration was determined using a Bradford protein assay (Thermo Fisher 617 
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Scientific). Protein samples, containing 50 µg total protein, was diluted 5 fold with 50 mM 618 
TEAB and protein digestion was performed at 37 °C for 18 h with shaking at 300 rpm. A 619 
protein to trypsin ratio of 50:1 was used. Trypsin digestion was stopped and peptides were 620 
desalted as described above.  621 
Mass spectrometry: Peptides were dissolved in 2% acetonitrile containing 0.1% TFA, and 622 
each sample was independently analysed on an Orbitrap Fusion Lumos Tribrid mass 623 
spectrometer (Thermo Fisher Scientific), connected to a UltiMate 3000 RSLCnano System 624 
(Thermo Fisher Scientific). Peptides were injected on an Acclaim PepMap 100 C18 LC trap 625 
column (100 μm ID × 20 mm, 3μm, 100Å) followed by separation on an EASY-Spray nanoLC 626 
C18 column (75 ID μm × 500 mm, 2μm, 100Å) at a flow rate of 300 nL/min. Solvent A was 627 
water containing 0.1% formic acid, and solvent B was 80% acetonitrile containing 0.1% 628 
formic acid. The gradient used for analysis of surface-shaved samples was as follows: 629 
solvent B was maintained at 3% for 6 min, followed by an increase from 3 to 35% B in 43 630 
min, 35-90% B in 0.5 min, maintained at 90% B for 5.4 min, followed by a decrease to 3% in 631 
0.1 min and equilibration at 3% for 10 min. The gradient used for analysis of proteome 632 
samples was as follows: solvent B was maintained at 3% for 6 min, followed by an increase 633 
from 3 to 35% B in 218 min, 35-90% B in 0.5 min, maintained at 90% B for 5 min, followed 634 
by a decrease to 3% in 0.5 min and equilibration at 3% for 10 min. The Oritrap Fusion 635 
Lumos was operated in positive ion data-dependent mode using a modified version of the 636 
recently described CHarge Ordered Parallel Ion aNalysis (CHOPIN) method for 637 
synchronised use of both the ion trap and the Orbitrap mass analysers49. The CHOPIN 638 
method is derived from the “Universal Method” developed by Thermo Fisher, to extend the 639 
capabilities of mass analyser parallelization. The precursor ion scan (full scan) was 640 
performed in the Orbitrap in the range of 400-1600 m/z with a resolution of 120 000 at 200 641 
m/z, an automatic gain control (AGC) target of 4 x 105 and an ion injection time of 50 ms. 642 
MS/MS spectra of doubly charged precursor ions were acquired in the linear ion trap (IT) 643 
using rapid scan mode after collision-induced dissociation (CID) fragmentation. A CID 644 
collision energy of 32% was used, the AGC target was set to 2 x 103 and a 300 ms injection 645 
time was allowed. Precursor ions with charge state 3-7 and with an intensity <5 x 105 were 646 
also scheduled for analysis by CID/IT, as described above. Precursor ions with charge state 647 
3-7 and with an intensity > 5 x105 were, however, acquired in the Oritrap (FT) with a 648 
resolution of 30 000 at 200 m/z after high-energy collisional dissociation (HCD). An HCD 649 
collision energy of 30% was used, the AGC target was set to 1 x 104 and a 40 ms injection 650 
time was allowed. The number of MS/MS events between full scans was determined on-the-651 
fly to maintain a 3 s fixed duty cycle. Dynamic exclusion of ions within a ± 10 p.p.m. m/z 652 
window was implemented using a 35 s exclusion duration. An electrospray voltage of 2.0 kV 653 
and capillary temperature of 275 °C, with no sheath and auxiliary gas flow, was used.  654 
Mass spectrometry data analysis: All tandem mass spectra were analysed using 655 
MaxQuant 1.5.1.750, and searched against a combined database of Bacteroides 656 
thetaiotaomicron VPI-5482 (containing 4782 entries), B. cellulosilyticus MGS:158 (containing 657 
4369 entries) and the B. cellulosilyticus BACCELL_00844 glycosyl hydrolase family 16 658 
protein. Protein sequences were downloaded from Uniprot on May 10th 2018. Peak list 659 
generation was performed within MaxQuant and searches were performed using default 660 
parameters and the built-in Andromeda search engine51. The enzyme specificity was set to 661 
consider fully tryptic peptides, and two missed cleavages were allowed. Oxidation of 662 
methionine, N-terminal acetylation and deamidation of asparagine and glutamine was 663 
allowed as variable modifications. No fixed modifications were employed in searches for the 664 
surface-shaved samples, whereas carbamidomethylation of cysteine was allowed as fixed 665 
modification in proteome searches. A protein and peptide false discovery rate (FDR) of less 666 
than 1% was employed in MaxQuant. Proteins were considered confidently identified when 667 
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they contained at least two unique tryptic peptides. Proteins that contained similar peptides 668 
and that could not be differentiated based on tandem mass spectrometry analysis alone 669 
were grouped to satisfy the principles of parsimony. Reverse hits and contaminants were 670 
removed before downstream analysis. Skyline 4.1.0.11796 was used for extraction of ion 671 
chromatograms52. Gene ontology (Ashburner et al. 2000) enrichment was performed using 672 
PANTHER53 and subcellular protein localization prediction was performed using LocateP 673 
v254. The mass spectrometry proteomics data have been deposited to the 674 
ProteomeXchange Consortium via the PRIDE partner repository with data set identifier 675 
PXD010274. 676 
 677 
Cross-feeding and competition assays 678 
Prior to co-culture each Bacteroides spp. was grown in TYG and washed in PBS before 679 
being used to inoculate MM containing 0.5% GA-AGP. Co-cultures were grown in triplicate. 680 
Samples of 0.5 ml were taken at regular intervals during growth, which were serially diluted 681 
and plated onto Brain-Heart Infusion (BHI, Sigma-Aldrich) with agar and porcine hematin for 682 
determination of total CFU/ml of the culture. Mono-cultures of each Bacteroides spp. were 683 
also plated for determination of CFU/ml at intervals during the growth. Genomic DNA was 684 
purified from the remainder of the co-culture sample (Bacterial genomic DNA purification kit, 685 
Sigma-Aldrich). Quantitative PCR (q-PCR) was performed in triplicate on each sample using 686 
a ROCHE Lightcycler 96 to determine the ratio of each Bacteroides spp. and mutants in the 687 
sample using primers specific for unique regions in each Bacteroides sp. genome. Primers 688 
for B. thetaiotaomicron (F:5’-AGGTGCAGGCAACCT-3’, R:5’-689 
AATTCCCGTTCTCCATGTCC-3’); B. ovatus (F:5’-690 
GGAATGAGCATAATCCATATATCAAGATGAAACG-3’, R:5’-691 
TACCTGAAACAATCATCCTTTATTTCTGTAGC-3’); B. cellulsoylticus (F:5’-692 
AGCAGGCGGAATTCGATAAG-3’ R:5’-GTGTACAGTGCCAGGCATAA-3’) and B. caccae 693 
(F:5’-GATTATGTGGACAGGTGATCGTGTGATTTC-3’, R:5’-694 
ATTCCACCAAATGTAGGCGGGACGTTTAAT-3’) were used to determine ratio of each 695 
species in co-culture and used to calculate the CFU/ml of each organisms in the culture. 696 
 697 
Crystal structure determination  698 
Crystallization: BT0290-E182A at 10 mg/ml, was crystallized from the commercial screen 699 
Morpheus (Molecular Dimensions, UK) condition D3 (20 mM 1,6-Hexanediol, 20 mM 1-700 
Butanol, 20 mM 1,2-Propanediol (racemic), 20 mM 2-Propanol, 20 mM 1,4-Butanediol, 20 701 
mM 1,3-Propanediol, 100 mM Imidazole-MES pH 6.5, 30% Glycerol and 30% polyethylene 702 
glycol 4000). Apo BT0265 was crystallised at 32 mg/ml in 20% PEG 3350 and 0.2 M 703 
Sodium/Potassium Tartrate. Crystals were cryoproteted with 20 % glycerol. Crystals of 704 
BT0265 Q249A were crystallised at 20 mg/ml, with a 200mg/ml oligosaccharide mixture, in 705 
20 % PEG 3350 and 0.2 M sodium thiocyanate. Crystals were cryo protected with paratone 706 
oil. 707 
BT3683 was crystallised at 12.6 mg/ml in 20 % PEG 3350, 0.2 M Ammonium formate and 708 
300 mM L-rhamnose. Crystals formed under these condiotns were then back soaked, in 709 
mother liquor overnight to remove the rhamnose. These crystals were then transferred to a 710 
fresh drop and soaked with galactose, galactodeoxynorijmycin or galactoimidazole, as 711 
desired, at concerntaions in >30 mM. These crystals were left overnight and then cryo 712 
protected with paratone oil. 713 
 714 
 715 
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Data collection and processing: Diffraction data for BT0290 and BT3674 were collected at 716 
the Diamond Light Source, U.K., on beamline I02, whilst, all other data was collected on 717 
bealine IO4-1, at a temperature of 100 °K. Alldata were processed and integrated with XDS 718 
and scaled using Aimless38, 39. For all datasets, the space groups were determined using 719 
pointless and later confirmed during refinement40. The phase problem was solved by 720 
molecular replacement using Phaser41. PDB 3D3A was used as search model for BT0290; 721 
BT3674 was solved using 4QJY; BT0265 was solved using 3VSF and a truncated version of 722 
BT0265, lacking the C-terminal Ig domain was used to solve BT3683. Additional automated 723 
model building for BT0265 was carried out using buccaneer42. Solvent molecules were 724 
added using COOT43 and checked manually. All other computing used the CCP4 suite of 725 
programs44.  Five percent of the observations were randomly selected for the Rfree set. The 726 
models were validated using Molprobity45. The data statistics and refinement details are 727 
reported in Supplementary Table 6. 728 
 729 
Comparative genomics analysis 730 
Using a similar strategy to the identification pectin PULs, AGP PULs were searched for in 731 
Bacteroidetes genomes. The identification of similar PULs was based on PUL alignments. 732 
Gene composition and order of Bacteroidetes PULs were computed using the PUL predictor 733 
described in PULDB46. Then, in a manner similar to amino acid sequence alignments, the 734 
predicted PULs were aligned to the appropriate pectin PULs according to their modularity as 735 
proposed in the RADS/RAMPAGE method47. Modules taken into account include CAZy 736 
families, sensor-regulators and suscd-like genes. Finally, PUL boundaries and limit cases 737 
were refined by BLASTP-based analysis. The glycoside hydrolase families discovered in this 738 
study are listed in the main text. 739 
 740 
Data availability. The data that support the findings of this study are available from 741 
the corresponding author upon request. The authors declare that the data supporting the 742 
findings of this study are available within the paper and the Supplementary Information. The 743 
crystal structure datasets generated (coordinate files and structure factors) have been 744 
deposited in the Protein Data Bank (PDB) and are listed in Supplementary Table 6 together 745 
with the PDB accession codes.   746 
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FIGURE LEGENDS 927 
 928 
Figure 1. The structure of arabinogalactans, PULs upregulated by the glycans and 929 
enzymes that attack these glycans. Structure of a, larch wood (LA-AGP) and b, gum 930 
arabic (GA-AGP) arabinogalactans, and the enzymes that act on these glycans. The 931 
enzymes are identified by their locus tag (BTXXXX and BaccellXXXX are derived from B. 932 
thetaiotaomicron and B. cellulosilyticus, respectively), assignment to cazy families (GHXX 933 
and PLXX indicate glycoside hydrolase and polysaccharide lyase families, respectively) and 934 
their predicted cellular location (based on the nature of the signal peptide and, in some 935 
cases, cellular location for the observed activity, proteomic analysis or resistance to 936 
proteinase K; see Fig. 5aef), in which superscript P and C indicate periplasmic and 937 
cytoplasmic location, respectively.and superscript. The black arrows show the linkage 938 
cleaved by the enzymes, although the polysaccharide lyase activity of BT0263 is not 939 
functionally relevant as it is located in the cytoplasm. We propose that the β-L-940 
arabinofuranose targeted by BT3674 is linked to the β1,3-galactan backbone at O2 or O4. 941 
This assumption is based on the observation that the enzyme potentiates the exo-β-1,3-942 
galactosidases that sequentially remove galactose units from the backbone (see Fig. 2a). 943 
These galactosidases can target galactose residues decorated at O6 but not at O2 or O4. c, 944 
Schematic of B. thetaiotaomicron polysaccharide utilization loci (PULs) upregulated by 945 
arabinogalactan degradation.  946 
 947 
Figure 2 HPAEC analysis of the activity of GH43_24 β1,3-D-galactanases The AGPs 948 
were at 5 mg/ml for all reactions except BT0264 against LA-AGP and BT3683 against GA-949 
AGP, when substrate concentration was increased to 25 mg/ml, the β-1,3-galactan 950 
backbone was at 1.5 mg/ml. Enzyme concentration was 1 µM. Reactions were incubated for 951 
16 h in 20 mM sodium phosphate buffer pH 7.0 containing 150 mM NaCl buffer. The data 952 
shown are representative of three independent replicates. a, reveals how the GH127 β-L-953 
arabinofuranosidase BT3674 acts in synergy with the exo-β1,3-galactosidases BT0265 and 954 
BT3683 on LA-AGP. The synergy between the endo-β1,3-galactanase with BT0265 and 955 
BT3683 acting on LA-AGP and GA-AGP was shown in b and c, respectively. d, shows a 956 
time course of BT0264 acting on β-1,3-galactan. Peaks containing a defined 957 
galactooligosaccharide are identified by a yellow circle with the degree of polymerization 958 
shown in subscript. In b and c the peaks corresponding to β1,6-galactobiose and β1,6-959 
galactotriose were identified by LC-MS (see Supplementary Fig. 1d), and the β1,6 linkage 960 
was revealed by sensitivity to the β1,6-galactosidase BT0290.   961 
 962 
Figure 3. The crystal structure of GH43_24 β1,3-D-galactosidases in complex with 963 
ligands. a, schematic of BT0265 (left) and BT3683 (right) in which the catalytic domains are 964 
colour ramped from blue at the N-terminus to red at the C-terminus. The C-terminal β-965 
sandwich domain in BT0265 is coloured cyan. b, shows the solvent exposed surface of 966 
BT0265 in complex with the heptasaccharide shown in Supplementary Fig. 3 (terminal α-967 
Gal and α-Rha are not visible). Electron density for the terminal α-Gal was too weak to 968 
model the sugar. The red dashes show the polar interactions between the ligand and both 969 
side chains and backbone N and O. Residues that make polar contacts with the side chain 970 
of the ligand are also shown. c, an overlay of the residues in BT0265 (cyan), BT3683 (green) 971 
and the GH43_24 β1,3-galactosidase Cthe_1271 (grey; PDB code 3VSZ) that interact with 972 
galactose (yellow) in complex with BT3683. d, BT3683 in complex with galactose (Gal), 973 
deoxygalactonojirimycin (DGJ) and galactose-imidazole (Gal-Im). Direct polar interactions 974 
between enzyme and ligand are indicated by black dashes and the indirect water-mediated 975 
hydrogen bonds in magenta dashes. The red dashed line represents the polar interaction 976 
between the catalytic acid (Glu520) and Ser487. The two conformations of Glu520 in the 977 
Gal-Im complex is denoted by a and b.  978 
 979 
 980 
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Figure 4. Degradation of GA-AGP side chains. The pentasaccharide substrate shown in a 981 
grey box was released from GA-AGP by the exo-β1,3-galactosidase BT0265 and then 982 
purified by size exclusion chromatography. Individual B. thetaiotaomicron enzymes (1 μM) 983 
were incubated with the glycan (5 mM) for 16 h at 37 oC in 20 mM sodium phosphate buffer, 984 
pH 7.0. Monosaccharides and oligosaccharides generated were identified by HPAEC-PAD. 985 
The data in a  and b show that the pentasaccharide  could be degraded by the enzymes that 986 
comprise the LU and RG pathways, respectively. Note that the enzymes in the two pathways   987 
Verification of the degradative pathway was achieved by reconstituting the pathway using 988 
the only functioned in the order shown in the figure. The example is representative of 989 
independent replicates (n = 3).  990 
  991 
 992 
Figure 5 Cell localization and growth of Bacteroides on complex AGPs. a, Western blot 993 
detection of BT0264 and a known surface enzyme (BT4662)30 in LA-AGP/heparin cultured 994 
B. thetaiotaomicron after treatment of the bacterial cells with proteinase K (PK+) or untreated 995 
(PK-). Purified recombinant BT0264 was also subjected to proteinase treatment to verify the 996 
enzyme is sensitive to the proteinase. The data show that the enzyme is resistant to the 997 
proteinase and thus is not located on the cell surface. The blot is an example of biological 998 
replicates where n=3. Wild type B. thetaiotaomicron (Bt) and B. thetaiotaomicron expressing 999 
Baccell00844 (Bt::Baccell00844) were cultured in 0.2 ml of minimal medium containing 1000 
AGPs under anaerobic conditions. b, growth was assessed on GA-AGP and GA-AGP pre-1001 
treated with BT0264 [GA-AGP(BT0264)] or Baccell00844 [GA-AGP(Baccell00844)]. In c 1002 
growth was evaluated on wheat AGP (WH-AGP). In b and c error bars report standard 1003 
errors of the mean  of biological replicates (n = 4). d, HPAEC analysis of the products 1004 
generated by recombinant Baccell00844 (1 μM) incubated with β-1,3-galactan for 16 h using 1005 
standard conditions. The chromatographs are examples of biological replicates (n = 2). e, 1006 
Bt, Bt::Baccell00844 and B. cellulosilyticus (Baccell) cells derived from cultured grown on 1007 
GA-AGP were incubated with 0.5% β1,3-galactan for 16 h in phosphate buffered saline 1008 
in aerobic conditions for 16 h. Under these conditions substrate is only available to 1009 
the surface enzymes. Products released from the glycan was evaluated by TLC. The 1010 
example is from biological replicates n =3. f, Venn diagram of the number of proteins 1011 
identified in the surfome, the surfome and total proteome, and total proteome.  Baccell00844 1012 
was unique to the surfome fraction. The 46 proteins detected only in the surfome are 1013 
described in Supplementary Table 5. 1014 
 1015 
 1016 
Figure 6. Growth profile of keystone and recipient Bacteroides species on complex 1017 
AGPs. Wild type B. thetaiotaomicron strain VPI-5482 (Bt), B. thetaiotaomicron strain VPI-1018 
5482 expressing Baccell00844 (Bt::Baccell00844), B. ovatus strain ATCC8483 (Bo), B. 1019 
cellulosilyticus strain DSM14838 (Baccell) and B. caccae strain ATCC 43185 (Bcacc) were 1020 
cultured on nutrient rich (TYG) media overnight. The organisms were then inoculated at ~107 1021 
colony forming units (CFUs) per ml into minimal medium containing GA-AGP at 0.5% (w/v), 1022 
either as a monoculture or in co-culture with one of the other strains. The cultures were 1023 
incubated in anaerobic conditions and at regular intervals aliquots were removed and plated 1024 
onto rich (BHI) agar plates to determine the CFUs. The ratio of the strains in the co-cultures 1025 
were determined by quantitative-PCR with primers that amplify genomic sequences unique 1026 
to each strain (see Methods for further details). (i)  shows the ratio of the organisms in the 1027 
co-cultures and (ii) the corresponding CFUs for these bacterial strains. Continuous lines 1028 
correspond to organisms in co-culture and broken lines are monocultures of the bacterial 1029 
strains. a, Bo and Bt; b, Bo and Baccell; c, Bo and Bcacc; d, Baccell and Bt;   e, Bcacc and 1030 
Bt; f, Bo and Bt::Baccell00844. Error bars represent the s.e.m of biological replicates (n=3). 1031 
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